New studies focus on vitamin D supplementation in pregnancy, for infants, children

Bottom Line: Vitamin D supplementation in pregnancy and for infants and children is the focus of two studies, an editorial and a patient page.

Why The Research Is Interesting: Vitamin D is essential for building and maintaining healthy bones and research suggests it may have other potential health benefits.

What: A randomized clinical trial of 975 healthy infants in Finland reports no difference in bone strength or incidence of infections at age 24 months when infants were given a higher daily dose of supplemental vitamin D (1,200 IU) compared with the standard dose (400 IU).

Authors: Sture Andersson, M.D., Ph.D., of the University of Helsinki and Helsinki University Hospital, Finland, and coauthors

Want to embed a link to this study in your story? Links will be live at the embargo time http://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2018.0602

(doi:10.1001/jamapediatrics.2018.0602)

What: A systematic review and meta-analysis of 24 randomized clinical trials examined vitamin D supplementation during pregnancy on several infant outcomes including small for gestational age, fetal or neonatal death, and congenital abnormality.

Authors: Shu Qin Wie, M.D., Ph.D., of University of Montreal, Canada, and coauthors

Want to embed a link to this study in your story? Links will be live at the embargo time http://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2018.0302

(doi:10.1001/jamapediatrics.2018.0302)

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Pfizer-BioNTech vaccine provides strong protection against MIS-C in children aged 5–17